Endoxana Injection 500 mg Powder for Solution for Injection
*Company:
Baxter Holding B.V.Status:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 27 July 2026
File name
iemt-pil-mockup-mitoxana1g2g_HA3002814 2026.pdf
Reasons for updating
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 02 August 2023
File name
Endoxana Inj 500mg & 1000mg Powder for Sol for Inj PIL HA-30-01-845_25JAN19_P01.pdf
Reasons for updating
- New PIL for new product
Updated on 23 January 2023
File name
ie-spc-2018-12-endoxanainj500mg-clean (1).pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 04 April 2022
File name
ie-spc-2018-12-endoxanainj500mg-clean.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Baxter Holding B.V.
Address:
Kobaltweg 49, 3542CE Utrecht, NetherlandsMedical Information E-mail:
medinfo_uki@baxter.comTelephone:
+44 (0)1635 206 345Medical Information Facsimile:
+44 (0)1635 206071Medical Information Direct Line:
+44 (0)1635 206345